Pharmaceutical Water

Pharmaceutical Water Market Size To Surge Past USD 50.7 Billion By 2027

SHARE THIS ARTICLE

The pharmaceutical water market size is estimated to reach US$ 50.7 billion by the end of 2027, registering a CAGR of 9.86% from 2020 to 2027. The report provides the overall revenue of the global pharmaceutical water market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

Growth Factors

Manufacturing of medicines need high-purity water in the manufacture process and the waste water stream can be profoundly laden with contaminants, toxins and organic nutrients which requires to be treated beforehand disposal, necessitating water and waste water treatment equipment. Development of the biopharmaceutical sector can be credited to large unmet medical requirements in the dealing chronic medical circumstances, patent expiry of patented biologic drugs that leads growth of biosimilar drugs, and a great number of clinical pipeline drugs. Furthermore, swift expansion of the vaccines sector is expected to push the biopharmaceutical industry in the near future. Hence, demand for pharmaceutical water is likely to rise, along with the development of the biopharmaceutical and generic injectable sectors throughout the estimate period.

High surge in burden of diabetes amongst the aged and obese populace around the globe is a major influence probable to push the global pharmaceutical water market throughout the prediction period. The pharmaceutical water market in Asia Pacific is expected to advance at a rapid rate throughout the prediction period. Growth of pharmaceutical water and other pharma products to manage with ailments and intensification in responsiveness leading to routine checkup and verdict are the main influences estimated to boost the growth of pharmaceutical water market in Asia Pacific.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1179

Report Highlights

  • The pharmaceutical & biotechnology companies segment captured a substantial cut of the total pharmaceutical water market in 2019
  • Growth of biopharmaceutical and generic injectable drugs businesses is probable to push the pharmaceutical water market during impending years
  • North America dominated the global pharmaceutical water market in 2019 and predicted to maintain the trend throughout forecast period.
  • Companies functioning in the generic injectable market are intensive on the expansion of generic injectable products, particularly generic biologic products such as biosimilars

Report Scope of the Pharmaceutical Water Market

Report Coverage Details
Market Size USD 50.7 Billion by 2027
Growth Rate CAGR of 9.86% from 2021 to 2027
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2027
Segments Covered Type, Application, Region
Companies Mentioned B. Braun Melsungen AG, Merck KGaA, Thermo Fisher Scientific, Inc., Baxter International, Inc., Intermountain Life Sciences, Cytiva (Danaher), Standard Reagents, Pvt. Ltd., FUJIFILM Irvine Scientific, CovaChem, LLC, Pfizer, Inc and Fresenius Kabi AG.

Regional Snapshots

The established economies of the U.S., Western Europe and Japan presently signify half of all expenditure in the global water for pharmaceuticals market. These nations are predicted to endure the largest markets for water technologies in this business over coming years.

Europe is the second largest pharmaceutical manufacturing markets and has appeared as a very profitable high value opening to stake holders in the water sector. Some of the principal companies have made noteworthy investments on research and development and also placing themselves as providers of professional solutions for the pharmaceutical industry. These funds are channeled to augment ground-breaking water and wastewater treatment solutions, examine and progress prevailing technologies to address the existing and anticipated fluctuations to the European Pharmacopoeia’s water standards.

In Japan, the ​growth in ​expenditure on ​water for ​pharma is ​anticipated to be ​higher, at ​about 4% annually. The governments is endorsing the augmented application of generic drugs, permitting for prolonged production capacities. In addition, best pricing guarantee restructurings will also go some way to easing the impacts of the patent cliff.

Key Players & Strategies

Equipment manufacturers are obeying with international pharmacopoeia standards. Leading-edge water purification systems are serving market participants in the pharmaceutical water sector to achieve recognition. Equipment firms are addressing customer specifications and necessities to upsurge the acceptance of systems. Pre-treatment activities are boosting the need for pharmaceutical-grade water purification systems. Region-specific requirements are being furnished by equipment manufacturers on account of diverse degrees of pre-treatment approaches.

Chief competitors contending in the global Pharmaceutical Water market are as follows:

  • Baxter International, Inc.
  • Merck KGaA
  • Braun Melsungen AG
  • Thermo Fisher Scientific, Inc
  • Cytiva (Danaher)
  • Fresenius Kabi AG
  • Pfizer, Inc.
  • CovaChem, LLC
  • Intermountain Life Sciences

Major Market Segments Covered:

By Type

  • HPLC Grade Water
  • Water for Injection

By Application

  • Pharmaceutical & Biotechnology Companies
  • Academics & Research Laboratories

By Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • United Kingdom
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC
      • North Africa
      • South Africa
      • Rest of Middle East & Africa

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research’s pharmaceutical water market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1179

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace &defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email:sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. Email: sales@flairinsight.com

View all posts by Precedence Research →

Leave a Reply

Your email address will not be published. Required fields are marked *